Acadian Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.1M | Buy |
1,267,989
+233,668
| +23% | +$6.46M | 0.07% | 223 |
|
|
2025
Q1 | $23M | Buy |
1,034,321
+651,700
| +170% | +$14.5M | 0.06% | 209 |
|
|
2024
Q4 | $7.56M | Buy |
382,621
+276,402
| +260% | +$5.46M | 0.02% | 418 |
|
|
2024
Q3 | $2.65M | Buy |
106,219
+48,989
| +86% | +$1.22M | 0.01% | 668 |
|
|
2024
Q2 | $1.07M | Sell |
57,230
-107,338
| -65% | -$2M | ﹤0.01% | 970 |
|
|
2024
Q1 | $3.24M | Buy |
164,568
+103,120
| +168% | +$2.03M | 0.01% | 560 |
|
|
2023
Q4 | $1.08M | Sell |
61,448
-164,733
| -73% | -$2.88M | ﹤0.01% | 839 |
|
|
2023
Q3 | $3.92M | Buy |
226,181
+203,933
| +917% | +$3.53M | 0.02% | 508 |
|
|
2023
Q2 | $310K | Buy |
22,248
+5,089
| +30% | +$70.9K | ﹤0.01% | 1175 |
|
|
2023
Q1 | $183K | Buy |
17,159
+4,145
| +32% | +$44.2K | ﹤0.01% | 1273 |
|
|
2022
Q4 | $193K | Buy |
+13,014
| New | +$193K | ﹤0.01% | 1285 |
|
|
2020
Q3 | – | Sell |
-14,021
| Closed | -$357K | – | 2265 |
|
|
2020
Q2 | $357K | Buy |
14,021
+8,326
| +146% | +$212K | ﹤0.01% | 1312 |
|
|
2020
Q1 | $88K | Buy |
+5,695
| New | +$88K | ﹤0.01% | 1375 |
|